Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Clinical trial NCT03279250 · COMPLETED

Trial details

NCT number: NCT03279250
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Adenocarcinoma Stage IIB Prostate Cancer AJCC v8 Stage IIC Prostate Cancer AJCC v8 Stage IIIA Prostate Cancer AJCC v8 Stage IIIC Prostate Cancer AJCC v8

Start date: 2017-10-13
Primary completion: 2021-05-11
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.